ALLYSA GUERRERO: Open Payments
NPI 1922729102 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 13 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $121 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $143 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| ABBVIE INC. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Eisai Inc. | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| TerSera Therapeutics LLC | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $28 |
| JAZZ PHARMACEUTICALS INC. | 1 | $27 |
Products named: AMS 700, AUSTEDO XR, LYNPARZA, HYQVIA, Lenvima, VENCLEXTA, Zoladex, Enhertu.
Industry payments across TX — which companies pay providers there.
